IMMUNOFORGE CO.,LTD.

City:

Seoul

Country:

South Korea

Published Applications:

Last publication date:

2025-09-18

Patent Grants:

Last grant date:

Top Inventors for applications by IMMUNOFORGE CO.,LTD.

These are the the leading inventors for applications assigned to IMMUNOFORGE CO.,LTD.:

Sung Min AHN 2 Seoul, South Korea
Nam Hui Kim 1 Daegu, South Korea
Hyun Jin Kwon 1 Seoul, South Korea
Myeong-Sook Jeong 1 Seoul, South Korea

Doohyun Lee 1 Daegu, South Korea
Eunkyu LEE 1 Seoul, South Korea
Ye Ri Han 1 Daegu, South Korea
Hyo-Ji Kim 1 Daegu, South Korea

Sang Bum KIM 1 Daegu, South Korea
So Young Kim 1 Daegu, South Korea
Hwan Geun Choi 1 Seoul, South Korea
Ji Young Kim 1 Seoul, South Korea

Seungyeon LEE 1 Daegu, South Korea
Eunhwa Ko 1 Incheon, South Korea
Chun Young IM 1 Daegu, South Korea
Kiho Chang 1 Seoul, South Korea

Sun Joo LEE 1 Daegu, South Korea
Jong-Won Kim 1 Seoul, South Korea
Kiho Chang 1 Incheon, South Korea
Sion Lee 1 Daegu, South Korea

Hyo-Jung CHOI 1 Incheon, South Korea
Heegyum Moon 1 Daegu, South Korea

Recent patent applications by IMMUNOFORGE CO.,LTD.

IMMUNOFORGE CO.,LTD. based in Seoul, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-09-18

US20250289861A1

Chemistry; metallurgy

FUSION PROTEIN COMPRISING GLP-1, IMMUNOGLOBULIN FC, AND IGF-1 AND USE THEREOF

#2 | 2023-09-21

US20230295153A1

Chemistry; metallurgy

3-((8-((1H-PYRAZOL-4-YL)AMINO)IMIDAZO[1,2-A]PYRIDIN-3-YL)ETHINYL)-N-PHENYLBENZAMIDE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

AssigneeID:

341733 ⎘